In hypertensive subjects hs-CRP and P disp are interrelated and associated with AF, suggesting an active implication of inflammation in the atrial electrophysiological remodeling predisposing to AF.
Atrial fibrillation (AF) represents the most common arrhythmia in adults and is associated with considerable morbidity and mortality. [1] [2] [3] In the Framingham Heart Study, hypertension and diabetes were identified as the sole independent predictors of AF 4, 5 whereas hypertension induced a 1.42 times greater risk of AF in the Manitoba Follow-Up study. 6 Atrial fibrosis and loss of atrial muscle mass represent the major pathoanatomic changes in AF. In hypertension atrial fibrosis is triggered, at least partly, by the increased hemodynamic load and the accompanying activation of various humoral and inflammatory pathways. From a pathophysiological point of view, these alterations in atrial histology seem to provide the substrate for atrial inhomogeneous conduction that result in AF. 7, 8 This nonhomogeneity of conduction has been shown to be expressed in the surface electrocardiogram (ECG) as increased interlead variability of P wave duration. P wave dispersion (P disp ) represents a novel electrocardiographic marker, which expresses the altered electrophysiological properties of the predisposed to fibrillation atria and contributes to the identification of subjects at risk for AF. 9, 10 Low grade inflammation participates, at least partially, in the pathogenetic mechanisms, which lead to increased hemodynamic load and the associated hypertensive target organ damage, such as left ventricular hypertrophy, arterial stiffening, and microalbuminuria. 11, 12 Moreover, inflammation has been recognized as a factor with the potential to mediate the induction or maintenance of AF [13] [14] [15] although it is uncertain whether any inflammatory changes represent a cause or consequence of AF. 16, 17 In this context increased high sensitivity C-reactive protein (hs-CRP) levels, the most established downstream marker of inflammation, have been associated with the development of AF 13 whereas lowering of CRP has been linked to a proportionally reduced AF incidence and recurrence. 14, 15 In this study, we investigated the interrelationships of inflammatory activation with atrial electrophysiological remodeling, in terms of hs-CRP and P disp , and their associations with AF in subjects with essential hypertension.
Methods
Study population. From our pool of hypertensive subjects in sinus rhythm we selected 50 consecutive subjects with at least two documented episodes of paroxysmal AF during the last Background Although inflammation has been shown to be implicated in the pathophysiology of atrial fibrillation (AF), little is known about its involvement in the accompanying atrial electrical remodeling expressed by P wave dispersion (P disp ).
Fifty hypertensive subjects with documented paroxysmal AF (AF group) and 50 matched for body mass index, sex and office systolic blood pressure (BP) subjects with no history of AF (SR group) were subjected to electrocardiogram (ECG) and P disp assessment, hs-CRP determination, a complete echocardiographic study and 24-h ambulatory BP monitoring.
results
The AF as compared to the SR subjects were older by 14 years (P < 0.0001) and they exhibited lower office and 24-h diastolic BP (7 mm Hg, P < 0.0001 and by 8 mm Hg, P < 0.0001, respectively) and higher office and 24-h pulse pressure (by 4 mm Hg, P = 0.03 and 6 mm Hg, P = 0.001, respectively) mean values. A higher mean of left atrial (LA) diameter index (by 1.9 mm/m 2 , P < 0.0001) and left ventricular mass index (by 16 g/m 2 , P < 0.0001) were observed in the AF vs. SR group. P disp mean and hs-CRP median values were higher in the AF group (by 22 ms, P < 0.0005 and by 4.63 mg/l, P < 0.0005, respectively). Standard multiple and multiple logistic regression analysis identified log 10 (hs-CRP) as independent determinant of P disp and log 10 (CRP) and P disp as independent determinants of AF.
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Inflammation and Electrical Remodeling in Fibrillation year (AF group) and 50 consecutive subjects with no history of AF (SR group) matched for sex, body mass index, and office systolic blood pressure (BP) levels.
The exclusion criteria included history or clinical evidence of coronary artery disease, congestive heart failure, valvular heart disease, chronic obstructive arterial disease, renal failure, diabetes mellitus, familial hypercholesterolemia, morbid obesity, and any noncardiac significant systemic disease. Moreover, none of the participants had any history of infection or inflammatory disease or recent (within the last month) surgery or trauma and none was under treatment with corticosteroids or nonsteroidal anti-inflammatory drugs. We also sought to exclude subjects with bundle branch block, atrioventricular block, ventricular pre-excitation, pacemaker implantation, and abnormal serum electrolyte values as well as subjects with no clear onset or offset of the P wave deflection from the isoelectric line in the 12-lead ECG. All AF subjects had discontinued any anti-arrhythmic treatment for a period of at least 4 weeks prior to enrollment in the study.
All study participants underwent 24-h ambulatory BP monitoring, 12-lead ECG for P disp assessment, a complete echocardiographic study and hs-CRP levels determination. The study protocol was approved by the ethics committee of our institution, was concordant with the Declaration of Helsinki and all participants gave written informed consent.
24-h Ambulatory BP monitoring. Ambulatory BP was recorded over a working day (Monday through Friday) using the automatic SpaceLabs unit 90217 (Redmond, WA). The procedure has been previously described in detail. 18 In brief, the cuff was fixed to the nondominant arm and the device was set to obtain automatic BP and heart rate readings at 15-min intervals during daytime and at 30-min intervals during night time. Short clock-fixed time intervals were used for the delineation of daytime and night time, defined as lasting from 10 am to 8 pm and from midnight to 6 am, respectively. The data were considered adequate when a minimum of 70% valid recordings were obtained during the 24-h measurement period.
Assessment of P disp in 12 lead, surface ECG. The ECG 12 lead were recorded simultaneously in a paper of 50 mm/s with 1 mV/cm standardization from all subjects, at the supine position after resting for at least 5 min. Subjects were instructed to keep still during ECG acquisition. The P wave duration was measured manually by an experienced investigator blinded to the subject's AF status, with the aid of a magnifying lens. The onset of the P wave was defined as the junction between isoelectric line and the beginning of the P wave deflection and the offset of the P wave as the junction between the end of the P wave deflection and the isoelectric line. The leads with the onset or offset of the P wave not clearly determined were excluded from the analysis. The average value of the P wave in each lead, from a 20 s recording, was estimated and afterwards the averaged maximum (P max ), and minimum (P min ) duration was recorded on each ECG. The P disp was defined as the difference between P max and P min . In order to assess the intraobserver reproducibility of P disp measurements, we repeated the P wave measurements in the same ECG in 15 patients 2 weeks after the first estimations. We found a significant correlation (r = 0.85) between the first and second P disp measurement.
Echocardiography. The echocardiographic studies were performed by an experienced senior echocardiographer blinded to the subject's AF status using a Vivid 3 PRO (General Electric, Milwaukee, WI) ultrasound imager equipped with a 2.5-5 MHz transducer, under continuous electrocardiographic recording according to the guidelines of the American Society of Echocardiography.
Left atrial (LA) diameter was measured by two-dimensional echocardiography obtained in the parasternal short-axis view at the base of the heart and was indexed for body surface area so as to provide the LA diameter index. Left ventricular mass index (LVMI) was calculated using the regression equation recommended by the American Society of Echocardiography and was indexed for body surface area to estimate LVMI. Measurement of diastolic function indexes such as transmitral E and A wave peak velocities, E to A wave peak velocities ratio, the transmitral flow E wave deceleration time and isovolumetric relaxation time was also performed in all subjects. The ejection fraction was determined by the Simpson method and fractional shortening was assessed with two-dimensional echocardiography. 19 Laboratory determinations. Venous blood sampling was performed between 8 am and 9 am after 12 h of fast and abstinence from smoking, alcohol, and caffeinated beverages, for the estimation of metabolic profile and hs-CRP concentrations. Estimated creatinine clearance was assessed by the Cockroft-Gault formula. Levels of hs-CRP were assessed using a validated high-sensitivity assay (Dade Behring CardioPhase hs-CRP Assay, Marburg, Germany) with intra-assay and interassay coefficient of variation of 3.4 and 2.1%, respectively, and a minimal detectable concentration of 0.175 mg/l. 20 Statistical analysis. All continuous variables with normal distributions are presented as means and standard deviations. The Kolmogorov-Smirnov statistic was used in order to test for any deviation from normality and the variables with nonnormally distributed scores are presented as median plus interquartile range. Due to skewed distribution the hs-CRP values were transformed logarithmically and the normal distribution of the transformed scores of the variable was confirmed before further analyses. The categorical variables are described with absolute values and relative frequencies. Differences between groups were determined with the Student's independent samples t-test or the χ 2 -test where appropriate. The relationships of each clinical and laboratory parameter with P disp were tested with Pearson bivariate correlation analysis. Variables exhibiting a significant relationship with P disp were further analyzed in a stepwise multiple linear regression analysis. Univariate logistic regression analysis was performed for the assessment of the relationships of AF with original contributions
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various clinical and laboratory variables. Variables identified by univariate analysis as significantly related to paroxysmal AF were entered in a forward stepwise multivariate logistic regression model for the identification of independent determinants of AF in our study population. We tested for interaction between the main determinants of AF by incorporating interaction terms in the regression equation. For the construction of the interaction terms we used the identified independent determinants of AF centered at their means for avoidance of multicolinearity.
The assumptions of each test used were checked for violations. Statistical significance was assumed at a level of P < 0.05. SPSS statistical package, release 15.0 (SPSS, Chicago, IL) was used for all statistical analyses.
results
The AF as compared to the SR subjects were older by 14 years (P < 0.0001) ( Table 1) . Apart from the matched gender, body mass index and office systolic BP they did not differ regarding waist-to-hip ratio and average 24-h systolic BP. The paroxysmal AF group in comparison with the SR group exhibited a lower office and 24-h diastolic BP (by 7 and 8 mm Hg, respectively, P < 0.0001 for both cases) and consequently a higher office and average 24-h pulse pressure (by 4 and 6 mm Hg, P = 0.03 and <0.01, respectively). With respect to their medical treatment, AF subjects were treated in a higher proportion with statins (10 vs. 1%, P = 0.02), renin-angiotensin-aldosterone system inhibitors (71 vs. 56%, P = 0.001), diuretics (27 vs. 20%, P = 0.02) and calcium channel blockers (39 vs. 26%, P = 0.03) ( Table 1) .
The echocardiographic measurements revealed a higher LA diameter index in the AF group (by 1.9 mm/m 2 , P < 0.0005) and a higher LVMI (by 16 g/m 2 , P < 0.0005). The AF compared to the SR subjects in regard with the indexes of diastolic performance exhibited a prolonged isovolumetric relaxation time (by 10 ms, P = 0.03) whereas they had a lower fractional shortening and ejection fraction (by 2 and 4%, P = 0.01 and <0.01, respectively). In terms of ECG-derived indexes regarding P wave variability, the AF group compared to the SR group exhibited a shorter P min (by 13 ms, P ≤ 0.01) and a greater P disp (by 22 ms, P < 0.0001). P max despite a trend for higher values in the AF subjects did not differ substantially in the two groups ( Table 2) .
No differences were observed between the two groups with reference to their glycemic profile, estimated creatinine clearance and serum potassium whereas the AF in comparison with the SR group exhibited lower LDL levels (by 19 mg/dl, Inflammation and Electrical Remodeling in Fibrillation P < 0.01) ( Table 1) . Concerning the inflammatory markers, AF subjects had higher mean log 10 (hs-CRP) values (by 0.55 mg/l, P < 0.001) that remained significant even after adjustment for age, 24-h DBP and baseline medical treatment.
In the entire study population, P disp was correlated with log 10 (hs-CRP) (r = 0.3, P < 0.01), age (r = 0.4, P < 0.0001), body mass index (r = 0.2, P = 0.04), 24-h diastolic BP (r = −0.4, P < 0.0001), 24-h pulse pressure (r = 0.2, P = 0.02), LA diameter index (r = 0.38, P < 0.0001), LVMI (r = 0.29, P < 0.01), ejection fraction (r = −0.3, P < 0.01), fractional shortening (r = −0.25, P = 0.01) and isovolumetric relaxation time (r = 0.3, P < 0.01). By stepwise multiple regression analysis it was identified that log-CRP, age, 24-h diastolic BP, and LVMI were independent determinants of P disp whereas waist-to-hip ratio, male sex, LA diameter index, and isovolumetric relaxation time were discarded from the regression model (Table 3) .
Two separate multivariate stepwise forward logistic regression models were constructed: model A without P disp , and model B with P disp in the set of the explanatory variables which also included age, gender, body mass index, 24-h diastolic BP, 24-h pulse pressure, LA diameter index, LVMI, ejection fraction, log 10 (hs-CRP), and low-density lipoprotein cholesterol, aiming at the identification of the independent determinants of AF. In model A age, left ventricular mass index, log 10 (hs-CRP), and 24-h diastolic BP constituted independent determinants of AF. In model A for each unit of increase in log 10 (hs-CRP) the odds that a hypertensive subject of our population belongs to the AF group increases by six times. In model B the odds that a subject belongs to the AF group increase by 1.3 times for every unit of increase in P disp and by 5.4 times for every unit of increase in log 10 (hs-CRP). Model A correctly classified our population of hypertensive subjects in the AF and SR groups with a sensitivity and specificity of 87.5 and 83.3%, respectively whereas the corresponding values of model B are 95.6 and 97.7% (Table 4) . No interactions were observed between age, log 10 (hs-CRP), LVMI and 24-h diastolic BP and age in model A or between age, P disp , and log 10 (hs-CRP) in model B.
discussion
The present study, apart from confirming that hypertensive subjects with a history of paroxysmal AF are characterized by elevated CRP levels and greater values of P disp , it demonstrates for the first time the association between P disp and CRP values. These findings support the notion that low grade inflammation is implicated in the electrophysiological remodeling of the atria in the setting of paroxysmal AF in hypertension.
Previous studies demonstrated increased levels of hs-CRP in paroxysmal AF subjects and even higher levels in subjects with persistent AF. 19 Associations of hs-CRP with AF have been demonstrated in postcardiac surgery patients 20 and a reduction of AF incidence and recurrence has been observed with hs-CRP reduction in a proportional manner. 14, 21 However there are data suggesting that an inverse or possibly a bidirectional relationship may exist, in which inflammation leads to AF and vice versa. 16, 17 In the setting of hypertension, accumulating data suggest that low grade inflammation in tandem with endothelial dysfunction and activation of renin-angiotensin-aldosterone 22 axis are implicated to the development of hypertensive target organ damage, 23 including left ventricular and atrial myocardium. Atrial fibrosis, loss of atrial myocardial mass and the associated structural heterogeneity of the atrial myocardium, account for the inter-and intra-atrial conduction disturbances and dispersion of the atrial refractory period 8 providing the electrophysiological substrate for AF; P disp reflects original contributions
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these abnormalities of conduction and has been identified as a marker of risk for the induction, and maintenance or recurrence of AF. 9, 24, 25 In accordance with the above, in the present study P disp was identified as an independent determinant of paroxysmal AF. Moreover a more intense inflammatory response was observed in hypertensives with paroxysmal AF, as compared to those with SR, whereas hs-CRP was an independent determinant of P disp . In addition, although hs-CRP was identified as independent determinant of paroxysmal AF, adjustment for P disp attenuates the relationship of CRP with AF, suggesting that P disp is a mediator between inflammation and AF. The above is in line with the notion that inflammation is involved in the electrophysiological remodeling of the atria in AF, at least, in the setting of hypertension. The relatively increased hs-CRP levels in the AF group may denote the involvement of hs-CRP in the inflammatory reaction of the atrial myocardium, the activation of the standard pathway of complement and consequently the myocardial tissue damage. In this sense effective anti-inflammatory treatment and hs-CRP lowering may provide benefits beyond reducing AF incidence and recurrence offering myocardial tissue protection. Moreover the failure of the more aggressive medical treatment of the AF group with renin-angiotensin-aldosterone system inhibitors and statins, to attenuate the differences in inflammatory activation, is compatible with a pathogenetic role of inflammation in AF.
study limitations
The cross-sectional nature of our study with no prospective data limits our ability to extract conclusions about the temporal relationships of inflammation and AF. The relatively limited cohort size restricts the generalizability of our results. The difference in age between the studied groups may remain an important confounding factor despite the appropriate statistical adjustments. The use of LA diameter as a measure of LA size instead of volume may be less accurate in case of eccentric atrial dilatation. The manual measurement of P disp although maybe less accurate compared to computerized methods, represents a straightforward and readily accessible mode of assessment of P wave interlead variability and in our case it was performed by one experienced investigator with high intraobserver reproducibility.
In conclusion, in hypertensive subjects, hs-CRP and P disp are interrelated and associated with paroxysmal AF, suggesting an active implication of inflammation in the atrial electrophysiological remodeling predisposing to AF. These findings highlight the potential prognostic role of increased CRP in the prediction of paroxysmal AF in hypertensive subjects. However this should be confirmed in prospective studies.
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